Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Titan Bio-Tech: Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended June 30 2026.
News Announcement

Titan Bio-Tech: Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended June 30 2026.

05-Aug-2026 Follow Value Research Online on Google download pdfDownload PDF Titan Bio-Tech

Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve the standalone and consolidated unaudited financial results for the quarter ended June 30 2026

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan